Michelson, Alan D <br/><br/>
Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial.  [electronic resource] 

 -  European heart journal  Jul 2009 
 - 1753-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-9645 
<br/><br/><label>Standard No.: </label>10.1093/eurheartj/ehp159  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Coronary Syndrome--drug therapy<br/>Adenosine Diphosphate--metabolism<br/>Angioplasty, Balloon, Coronary--methods<br/>Cell Adhesion Molecules--metabolism<br/>Clopidogrel<br/>Female<br/>Humans<br/>Male<br/>Microfilament Proteins--metabolism<br/>Middle Aged<br/>Myocardial Infarction--drug therapy<br/>Phosphoproteins--metabolism<br/>Phosphorylation<br/>Piperazines--adverse effects<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Prasugrel Hydrochloride<br/>Thiophenes--adverse effects<br/>Ticlopidine--adverse effects<br/>Vasodilator-Stimulated Phosphoprotein